JPRN-UMIN000044972已完成未知
Incidence of immune checkpoint inhibitor-induced arthritis - Systematic review
Yokohama City University Graduate School of Medicine0 个研究点目标入组 14,377 人开始时间: 2021年7月27日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 14,377
研究概览
简要总结
Please refer to the following: Rheumatology (Oxford). 2022 Sep 7;keac519. doi: 10.1093/rheumatology/keac519. Online ahead of print.
研究设计
- 研究类型
- Others,meta-analysis etc
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Systematic review or meta-analysis articles. (2) Retrospective analysis. (3) Single prospective cohort study without a control group. (4) Non-RCT. (5) The republished research literature is excluded unless the research includes new findings related to adverse events listed in inclusion criteria. (6) Studies with no or insufficient safety results at the time of the literature search. (7) Studies published in languages other than English.
研究者
相似试验
已完成
不适用
Incidence of immune checkpoint inhibitor-related myositisJPRN-UMIN000044960Yokohama City University Graduate School of Medicine12,866
已完成
不适用
Checkpoint Inhibitor Induced Colitis and Arthritis -Immunomodulation With IL-6 Blockade and Exploration of Disease MechanismsSolid TumorArthritisColitisNCT03601611Herlev Hospital20
已完成
不适用
Immune CHeckpoint Inhibitors Monitoring of Adverse Drug ReActionArthritisCardiac DiseaseEndocrine System DiseasesAutoimmune DiseasesOphthalmopathyNeuropathyCancerMyositisNCT03492242Groupe Hospitalier Pitie-Salpetriere1,000
已完成
不适用
Evaluation of Reporting of Immune Checkpoint Inhibitor Associated Cardio-vascular Adverse ReactionsCardiac ComplicationMyocarditisNCT03387540Groupe Hospitalier Pitie-Salpetriere104
招募中
不适用
Immune checkpoint inhibition associated cardiovascular adverse events in cancer patientscardiovascular disease (CVD)heart and vascular disease100110821002765510014523NL-OMON51839Academisch Medisch Centrum214